However, there was a modest but significant reduction in the number of KPC cells by day 5 of 4μ8C treatment (Fig. S5A) suggesting that inhibition of the IRE1α/XBP1 signaling can potentially inhibit KPC tumor growth in vivo. Here, XBP1 is linked to neoplasm.